Oxindanac
Oxindanac is a nonsteroidal anti-inflammatory agent. Oxindanac produces inhibition of serum TxB2 production. Oxindanac reduces the volume of swelling. Oxindanac shows analgesic activity[1].
Product Specifications
CAS Number
[68548-99-2]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
COX
Related Pathways
Immunology/Inflammation
Field of Research
Neurological Disease; Inflammation/Immunology
Smiles
O=C(O)C1C2=CC(O)=C(C=C2CC1)C(=O)C=3C=CC=CC3
Molecular Formula
C17H14O4
Molecular Weight
282.30
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]King JN. The use of intradermal carrageenan in calves to estimate the dose of oxindanac, a nonsteroidal anti-inflammatory drug. Can J Vet Res. 1993 Oct;57 (4) :215-22.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1150288-01 0.02 mg (E-Coli)
Recombinant Polaromonas naphthalenivorans UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
Ask
View Details 
MBS1150288-02 0.02 mg (Yeast)
Recombinant Polaromonas naphthalenivorans UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
Ask
View Details MBS1150288-03 0.1 mg (E-Coli)
Recombinant Polaromonas naphthalenivorans UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
Ask
View Details